XML 32 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 15,759  
Operating expenses:    
Research and development 37,547 $ 26,379
Acquired in-process research and development 23,049  
General and administrative 17,239 11,407
Total operating expenses 77,835 37,786
Loss from operations (62,076) (37,786)
Other expense, net:    
Interest expense (1,053) (1,073)
Interest income 420 57
Other income (expense), net 281 (250)
Total other expense , net (352) (1,266)
Net loss (62,428) (39,052)
Other comprehensive income, net:    
Unrealized loss on available-for-sale securities, net (38) (59)
Foreign currency translation gain 252 218
Total other comprehensive income, net 214 159
Comprehensive loss $ (62,214) $ (38,893)
Net loss per share, basic $ (1.85) $ (1.36)
Net loss per share, diluted $ (1.85) $ (1.36)
Weighted-average number of common shares outstanding, basic 33,727,945 28,806,310
Weighted-average number of common shares outstanding, diluted 33,727,945 28,806,310